Insider · CIK 0002039135
Susan Eylward
Files at IMNN (Imunon, Inc.). First filing Jun 29, 2026, latest Sep 1, 2026.
Susan Eylward files SEC Form 4 as officer at IMNN (Imunon, Inc.). Since Jun 29, 2026, Susan Eylward has reported 0 open-market buys worth $0 and 2 open-market sells worth $25k, the latest filed on Sep 1, 2026.
A track record needs three past buys with six months of prices behind them; Susan Eylward has 0, so none is measured yet.
The newest scored trade: sold $3,950 of IMNN on Aug 31, 2026, filed Sep 1, 2026, scored 25 (weak). In the last 12 months: 0 buys worth $0 and 2 sells worth $25k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMNN: Imunon, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | IMNNsell Imunon, Inc. | $3,950 2,525 shares | -47% | - | |
| 35Weak | IMNNsell Imunon, Inc. | $21k 11,800 shares | -80% | +5% from low-83% from high |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | IMNN Imunon, Inc. | AGrant or award Common Stock | +2,525 | $1.60 | $4,040 | 5,421 | 42 d ago |
| Aug 31, 2026 | IMNN Imunon, Inc. | SOpen-market sale Common Stock | -2,525 | $1.56 | $3,950 | 2,896 | 42 d ago |
| Jun 25, 2026 | IMNN Imunon, Inc. | AGrant or award Common Stock | +14,696 | $1.72 | $25k | 14,696 | Jun 29, 2026 |
| Jun 29, 2026 | IMNN Imunon, Inc. | SOpen-market sale Common Stock | -11,800 | $1.75 | $21k | 2,896 | Jun 29, 2026 |
| Jan 2, 2026 | IMNN Imunon, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +8,251 | $0.00 | $0 | 8,251 | Jan 6, 2026 |
| Aug 4, 2025 | IMNN Imunon, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +417 | $0.00 | $0 | 417 | Aug 6, 2025 |
| Mar 14, 2025 | IMNN Imunon, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +6,250 | $0.00 | $0 | 6,250 | Mar 18, 2025 |
Questions about Susan Eylward
Answered from the filings on this page, as of the latest one.
Is Susan Eylward buying or selling?
In the last 12 months Susan Eylward reported 0 open-market buys worth $0 and 2 open-market sells worth $25k on SEC Form 4; the latest was sold $3,950 of IMNN on Aug 31, 2026. Grants, option exercises and tax withholding are not counted.
How did Susan Eylward's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Susan Eylward has 0.
Where does Susan Eylward file Form 4?
Susan Eylward has filed Form 4 at IMNN (Imunon, Inc.) as General Counsel and Corp Sec. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.